45 Participants Needed

Early Intervention for Language Delay

Recruiting at 1 trial location
KN
NB
Overseen ByNicole Bazzocchi, MhSc
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The trial aims to assist young children who are late talkers by examining how their brains function during language learning. Children in the trial will either receive immediate intervention to address late talking or receive help later. Researchers will use special brain scans and activities to observe changes in language learning over time. Children between 18 and 30 months old, who primarily speak English and are enrolled at specific locations, may be suitable candidates for this trial. As an unphased trial, it offers parents a unique opportunity to contribute to groundbreaking research that could enhance their child's language development.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that this intervention is safe for children with language delay?

Research has shown that programs designed to help late talkers, such as those teaching parents how to support their child's language skills, are generally safe and well-received. These programs primarily instruct parents on methods to aid their child's language development. They have been successfully used to manage language delays without significant safety concerns.

While detailed safety data from clinical trials may not be available, these programs focus on guidance and activities rather than medicine or medical procedures, indicating a low risk of issues. The emphasis is on improving grammar, vocabulary, and communication through structured support, which is unlikely to cause harm.

For those considering joining a trial, this type of program focuses on learning and support, making it a generally safe choice for children and parents.12345

Why are researchers excited about this trial?

Researchers are excited about this early intervention for language delay because it takes a unique two-pronged approach. Unlike traditional speech therapy, which often focuses solely on direct interaction with the child, this treatment actively involves parents through adult learning to enhance their ability to support their child's language development. By combining parental education with direct support for late-talking children, the intervention aims to improve grammar, vocabulary, and functional communication in just 6 to 8 weeks. This holistic method could potentially lead to faster and more sustainable improvements than current options, making it a promising new path for helping children with language delays.

What evidence suggests that this trial's treatments could be effective for late talking?

This trial will compare an intervention program for late talking with a waitlist control group. Research has shown that assisting children who begin talking later than usual can be very effective. One study found that speech and language therapy significantly improves vocabulary in these children. Another study confirmed that parental involvement also boosts language development in late talkers. These methods focus on enhancing grammar, vocabulary, and everyday communication. While many late talkers eventually catch up independently, early intervention can accelerate progress and reduce language difficulties.678910

Who Is on the Research Team?

KN

Karla N Washington, PhD

Principal Investigator

University of Toronto

Are You a Good Fit for This Trial?

This trial is for children aged 18-30 months who are late talkers and primarily English-speaking without vision issues. They must be enrolled at a participating facility, have no MRI contraindications like metal implants or claustrophobia, and not be in special education due to ability or behavior.

Inclusion Criteria

Child does not have any uncorrected vision challenges
Child does not have any contraindications to magnetic resonance imaging (i.e., intracranial metal implants, claustrophobia)
Child is enrolled at one of the participating facilities
See 2 more

Exclusion Criteria

Standard magnetic resonance imaging exclusion criteria
Child does not meet criteria for LT or typical development
Gestational age less than 37 weeks or greater than 42 weeks
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks

Treatment

Participants receive an intervention program addressing late talking, including parent coaching and direct therapy for children, over 6 to 8 weeks.

6 to 8 weeks
Weekly visits (in-person or virtual)

Follow-up

Participants are monitored for treatment-related changes in language function and structural connectivity.

8 to 9 weeks
3 visits (in-person)

Open-label extension (optional)

Participants may continue to receive intervention after the main study period.

Long-term

What Are the Treatments Tested in This Trial?

Interventions

  • Intervention to address late talking
Trial Overview The study aims to understand the brain and behavioral aspects of late talking in toddlers using neuroimaging techniques and behavioral assessments. It seeks to identify memory-language mechanisms that could inform tailored interventions for language development disorders.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention to address late talkingExperimental Treatment1 Intervention
Group II: Waitlist controlsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Toronto

Lead Sponsor

Trials
739
Recruited
1,125,000+

Georgetown University

Collaborator

Trials
355
Recruited
142,000+

Children's Hospital Medical Center, Cincinnati

Collaborator

Trials
844
Recruited
6,566,000+

Holland Bloorview Kids Rehabilitation Hospital

Collaborator

Trials
69
Recruited
14,100+

University of Cincinnati

Collaborator

Trials
442
Recruited
639,000+

Published Research Related to This Trial

Interventions for children aged 24-36 months with late language emergence showed significant improvements in language skills, with medium to large effect sizes reported in good-quality studies involving 275 participants.
Focused stimulation and modeling of single words were particularly effective treatment strategies, suggesting that targeted approaches can enhance language development in late talkers.
Systematic review of the literature on the treatment of children with late language emergence.Cable, AL., Domsch, C.[2018]
A parent-implemented dialogic book reading intervention significantly improved expressive language skills in 31-month-old late talkers, with more children in the intervention group recovering from their language delays compared to the control group.
Both low-risk preterm and full-term children benefited from the intervention, with notable increases in the production of complete sentences and overall vocabulary growth, suggesting this approach is effective and cost-efficient for enhancing language development.
A Parent-Implemented Language Intervention for Late Talkers: An Exploratory Study on Low-Risk Preterm and Full-Term Children.Zuccarini, M., Suttora, C., Bello, A., et al.[2023]
Late talking in toddlers can lead to significant long-term impacts on socialization and school readiness, highlighting the need for early intervention rather than a wait-and-see approach.
Parent-implemented interventions can effectively address the risks associated with late talking and enhance protective factors, utilizing existing interprofessional practice frameworks in early intervention programs.
Late Talkers: Why the Wait-and-See Approach Is Outdated.Capone Singleton, N.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/12918003/
Speech and language therapy interventions for children ...The results suggest that speech and language therapy is effective for children with phonological (SMD=0.44, 95%CI: 0.01,0.86) or vocabulary difficulties (SMD= ...
Effects in language development of young children with ...This study tests the hypothesis that children with LD show progress in their receptive and expressive language during intervention.
Late Language EmergenceLate language emergence is a delay in language onset with no other diagnosed disabilities or developmental delays in other cognitive or motor domains.
The Effects of a Parent-Implemented Language ...We conclude that the parent-implemented intervention was effective in supporting late-talkers' gains in language development as a cascade result ...
Late Talkers - Language Development, Interventions, and ...Experts argued that the available outcome data revealing that most. LTs grow out of their delays are short-term, and they cannot be depended on for decisions ...
Language Outcomes of Late Talking Toddlers at Preschool ...Late talkers ultimately “recover” and develop adequate language skills, or if late talking in toddlerhood is a precursor to difficulties with language.
Late Talkers: A Population-Based Study of Risk Factors ...Being a late talker increased children's risk of having low vocabulary at 48 months and low school readiness at 60 months.
Parent-Implemented Language Intervention for Late TalkersParent-implemented language intervention (PILI) is one of the intervention approaches used in managing late talkers (LTs).
Late Talkers - Language Development, Interventions, and ...Experts argued that the available outcome data revealing that most. LTs grow out of their delays are short-term, and they cannot be depended on for decisions ...
Towards a Characterization of Late TalkersIn this study, a web-based assessment survey was developed to (1) describe the relation between expressive vocabulary, Socio-Conversational Skills (SCS), ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security